UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 172

Sortiert nach

Editorial for the IJMS Special Issue on Sglt2 Inhibitors (Volume 2)

International journal of molecular sciences, 2023-12, Vol.24 (23), p.16865

Lymperopoulos, Anastasios

2023

Link zum Volltext

Verfügbarkeit prüfen

Editorial to the IJMS Special Issue on Sglt2 Inhibitors Vol. 1

International journal of molecular sciences, 2023-04, Vol.24 (8), p.6873

Lymperopoulos, Anastasios

2023

Link zum Volltext

Verfügbarkeit prüfen

Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors

Current pharmaceutical design, 2012-01, Vol.18 (2), p.192

Lymperopoulos, Anastasios

2012

Link zum Volltext

Verfügbarkeit prüfen

Short-Chain Fatty Acid Receptors and Cardiovascular Function

International journal of molecular sciences, 2022-03, Vol.23 (6), p.3303

2022

Link zum Volltext

Verfügbarkeit prüfen

Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland

International journal of molecular sciences, 2021-07, Vol.22 (14), p.7684

2021

Link zum Volltext

Verfügbarkeit prüfen

The therapeutic potential of targeting cardiac RGS4

Therapeutic Advances in Cardiovascular Disease, 2023-01, Vol.17, p.17539447231199350-17539447231199350

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiac RGS Proteins in Human Heart Failure and Atrial Fibrillation: Focus on RGS4

International journal of molecular sciences, 2023-03, Vol.24 (7), p.6136

2023

Link zum Volltext

Verfügbarkeit prüfen

Adrenal angiotensin II type 1 receptor biased signaling: The case for “biased” inverse agonism for effective aldosterone suppression

Cellular signalling, 2021-06, Vol.82, p.109967-109967, Article 109967

2021

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology of Sepsis-Related Cardiac Dysfunction: Driven by Inflammation, Energy Mismanagement, or Both?

Current heart failure reports, 2015-04, Vol.12 (2), p.130-140

2015

Link zum Volltext

Verfügbarkeit prüfen

βArrestins in cardiac G protein-coupled receptor signaling and function: partners in crime or "good cop, bad cop"?

International journal of molecular sciences, 2013-12, Vol.14 (12), p.24726-24741

2013

Link zum Volltext

Verfügbarkeit prüfen

Editorial for the IIJMS/I Special Issue on Sglt2 Inhibitors

International journal of molecular sciences, 2023-11, Vol.24 (23)

Lymperopoulos, Anastasios

2023

Link zum Volltext

Verfügbarkeit prüfen

Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment Contractility

International journal of molecular sciences, 2022-09, Vol.23 (19), p.11315

2022

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy

World journal of cardiology, 2017-03, Vol.9 (3), p.200-206

2017

Link zum Volltext

Verfügbarkeit prüfen

Editorial to the IIJMS/I Special Issue on Sglt2 Inhibitors Vol. 1

International journal of molecular sciences, 2023-04, Vol.24 (8)

Lymperopoulos, Anastasios

2023

Link zum Volltext

Verfügbarkeit prüfen

Autonomic Nervous System Regulation of Epicardial Adipose Tissue: Potential Roles for Regulator of G Protein Signaling-4

Current issues in molecular biology, 2022-12, Vol.44 (12), p.6093-6103

2022

Link zum Volltext

Verfügbarkeit prüfen

GRK2 inhibition in heart failure: something old, something new

Current pharmaceutical design, 2012-01, Vol.18 (2), p.186

2012

Link zum Volltext

Verfügbarkeit prüfen

The place of ARBs in heart failure therapy: is aldosterone suppression the key?

Therapeutic Advances in Cardiovascular Disease, 2019, Vol.13, p.1753944719868134-1753944719868134

2019

Link zum Volltext

Verfügbarkeit prüfen

Regulator of G-Protein Signaling-4 Attenuates Cardiac Adverse Remodeling and Neuronal Norepinephrine Release-Promoting Free Fatty Acid Receptor FFAR3 Signaling

International journal of molecular sciences, 2022-05, Vol.23 (10), p.5803

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol

Current drug metabolism, 2016-01, Vol.17 (1), p.30

2016

Link zum Volltext

Verfügbarkeit prüfen

Deletion of Osteopontin Enhances β₂-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes

International journal of molecular sciences, 2019-03, Vol.20 (6), p.1396

2019

Link zum Volltext

Verfügbarkeit prüfen

Chemically synthesized Secoisolariciresinol diglucoside (LGM2605) improves mitochondrial function in cardiac myocytes and alleviates septic cardiomyopathy

Journal of molecular and cellular cardiology, 2019-02, Vol.127, p.232-245

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease

International journal of molecular sciences, 2018-11, Vol.19 (12), p.3764

2018

Link zum Volltext

Verfügbarkeit prüfen

Adrenal Beta-Arrestin 1 Inhibition In Vivo Attenuates Post-Myocardial Infarction Progression to Heart Failure and Adverse Remodeling Via Reduction of Circulating Aldosterone Levels

Journal of the American College of Cardiology, 2011-01, Vol.57 (3), p.356-365

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical pharmacology of cardiac cyclic AMP in human heart failure: too much or too little?

Expert review of clinical pharmacology, 2023-07, Vol.16 (7), p.623-630

Lymperopoulos, Anastasios

2023

Link zum Volltext

Verfügbarkeit prüfen

adrenal β-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo

Proceedings of the National Academy of Sciences - PNAS, 2009-04, Vol.106 (14), p.5825-5830

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Englisch
(172)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(69)
Humans
(50)
Animals
(46)
Heart Failure
(43)
Signal Transduction
(40)
Proteins
(23)
Cardiovascular System & Cardiology
(22)
Rats
(22)
Biochemistry & Molecular Biology
(21)
Heart
(21)
Cardiac & Cardiovascular Systems
(20)
Kinases
(20)
Aldosterone
(19)
Pharmacology & Pharmacy
(17)
Cardiovascular
(14)
Receptors
(13)
Receptors, G-Protein-Coupled - Metabolism
(13)
Adrenergic Receptors
(12)
Cell Biology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Editorial for the IJMS Special Issue on Sglt2 Inhibitors (Volume 2)

Editorial to the IJMS Special Issue on Sglt2 Inhibitors Vol. 1

Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors

Short-Chain Fatty Acid Receptors and Cardiovascular Function

Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland

The therapeutic potential of targeting cardiac RGS4

Cardiac RGS Proteins in Human Heart Failure and Atrial Fibrillation: Focus on RGS4

Adrenal angiotensin II type 1 receptor biased signaling: The case for “biased” inverse agonism for effective aldosterone suppression

Pathophysiology of Sepsis-Related Cardiac Dysfunction: Driven by Inflammation, Energy Mismanagement, or Both?

βArrestins in cardiac G protein-coupled receptor signaling and function: partners in crime or "good cop, bad cop"?

Editorial for the IIJMS/I Special Issue on Sglt2 Inhibitors

Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment Contractility

Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy

Editorial to the IIJMS/I Special Issue on Sglt2 Inhibitors Vol. 1

Autonomic Nervous System Regulation of Epicardial Adipose Tissue: Potential Roles for Regulator of G Protein Signaling-4

GRK2 inhibition in heart failure: something old, something new

The place of ARBs in heart failure therapy: is aldosterone suppression the key?

Regulator of G-Protein Signaling-4 Attenuates Cardiac Adverse Remodeling and Neuronal Norepinephrine Release-Promoting Free Fatty Acid Receptor FFAR3 Signaling

Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol

Deletion of Osteopontin Enhances β₂-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes

Chemically synthesized Secoisolariciresinol diglucoside (LGM2605) improves mitochondrial function in cardiac myocytes and alleviates septic cardiomyopathy

Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease

Adrenal Beta-Arrestin 1 Inhibition In Vivo Attenuates Post-Myocardial Infarction Progression to Heart Failure and Adverse Remodeling Via Reduction of Circulating Aldosterone Levels

Clinical pharmacology of cardiac cyclic AMP in human heart failure: too much or too little?

adrenal β-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo

Suchergebnisse filtern